A pain-relieving medication might be safer for seniors than first thought. A new study published Jan. 7 in the Annals of ...

SPRINGFIELD, Ill. – The Illinois Department of Public Health (IDPH) has approved four new conditions for treatment with medicinal cannabis, a first in six years. Approved under Illinois law following ...

A Danish study has found that semaglutide, which controls blood glucose while ensuring weight loss, is associated with a ...

Cold weather can be difficult for cancer patients. Here are a few tips from the Oncologist to stay healthy during the winter ...

CIDRAP: Early-Life Infection Burden Continues Throughout Childhood, New Data Reveal New data from researchers in Denmark suggest that children who have a lot of common infections early in life ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

French biochemist Jessie Inchauspé is sharing her tips to lower blood glucose levels, as part of her new Channel 4 show.

China NMPA approves Astellas Pharma’s Padcev in combination with Keytruda to treat advanced bladder cancer: Tokyo Thursday, January 9, 2025, 09:00 Hrs [IST] Astellas Pharma Inc.

The NRG-HN004 trial showed that durvalumab did not improve outcomes vs cetuximab in locoregionally advanced head and neck squamous cell carcinoma undergoing radiotherapy with contraindications to ...

Your guide to the most important world stories of the day Essential analysis of the stories shaping geopolitics on the continent The latest news, analysis, and data from the country each week ...